Hospital
Garnet Health Medical Center
Garnet Health Medical Center was paid $45.17M by Medicaid between Jan 2018 and Dec 2024, across 253 billing codes. Its largest line is 99284, emergency room visit (serious) — 17% of everything it billed.
33Billing provider infoGARNET HEALTH MEDICAL CENTER
MIDDLETOWN, NY 10940
MIDDLETOWN, NY 10940
33aNPI1609875772assigned 07/20/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$45.17M
24GClaims728,260
24DCodes billed253
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in New York
Rank by total paid#33 of 231
Median peer was paid$561K
This provider vs. median81×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 30,242 | $808K | |
| 2019 | 66,007 | $3.01M | |
| 2020 | 127,602 | $7.37M | |
| 2021 | 142,168 | $8.54M | |
| 2022 | 139,271 | $9.14M | |
| 2023 | 130,584 | $9.29M | |
| 2024incomplete | 92,386 | $7.01M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 17% | 43,170 | 39,656 | $7.47M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 15% | 35,424 | 33,412 | $6.83M |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 6.9% | 10,324 | 7,053 | $3.10M |
| 96361 | Intravenous infusion, hydration; each additional hour | 4.6% | 6,794 | 6,153 | $2.09M |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 4.4% | 8,385 | 2,215 | $1.98M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.8% | 5,766 | 5,636 | $1.73M |
| 90791 | Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation | 3.2% | 6,218 | 5,331 | $1.46M |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 3.2% | 3,297 | 3,238 | $1.44M |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.7% | 55,494 | 34,678 | $1.23M |
| 70450 | Computed tomography, head or brain; without contrast material | 2.7% | 4,597 | 4,468 | $1.22M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 2.2% | 1,179 | 1,178 | $975K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 2.1% | 2,179 | 2,157 | $940K |
241 more codes
| 99214 | Doctor's office visit, returning patient (more involved) | 1.6% | 5,824 | $738K |
| G0378 | Hospital observation service, per hour | 1.4% | 6,683 | $639K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1.4% | 1,814 | $626K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1.4% | 2,360 | $616K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.3% | 2,110 | $586K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1.2% | 8,625 | $537K |
| 99213 | Doctor's office visit, returning patient (routine) | 1.0% | 3,446 | $460K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 1,530 | $449K |
| 80076 | <1% | 32,604 | $426K | |
| 93970 | <1% | 732 | $422K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 52,680 | $419K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 2,495 | $393K |
| 77336 | <1% | 579 | $344K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 1,146 | $329K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 3,794 | $308K |
| 93458 | <1% | 159 | $303K | |
| 86850 | <1% | 6,675 | $282K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 2,733 | $279K |
| 99285 | Emergency room visit (most serious) | <1% | 1,629 | $257K |
| 76801 | <1% | 2,009 | $236K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 5,698 | $235K |
| 86901 | <1% | 6,663 | $208K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 591 | $207K |
| 96367 | <1% | 1,322 | $198K | |
| 80053 | Comprehensive metabolic panel | <1% | 7,808 | $181K |
| 96415 | <1% | 257 | $176K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 1,597 | $172K |
| 97162 | <1% | 870 | $172K | |
| 12001 | <1% | 314 | $168K | |
| 70496 | <1% | 572 | $163K | |
| 77412 | <1% | 379 | $160K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 1,128 | $160K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 2,005 | $159K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,977 | $150K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 143 | $150K |
| 86900 | <1% | 6,664 | $148K | |
| 88342 | <1% | 1,954 | $145K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 4,146 | $135K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 1,345 | $123K |
| S9480 | Intensive outpatient psychiatric services, per diem | <1% | 497 | $119K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 308 | $117K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 3,157 | $115K |
| 12011 | <1% | 214 | $113K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 110 | $111K |
| 83880 | <1% | 3,176 | $99K | |
| 97602 | <1% | 640 | $98K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 7,993 | $98K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 103 | $92K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 128 | $91K |
| 93971 | <1% | 909 | $88K | |
| G0396 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | <1% | 480 | $84K |
| 87631 | <1% | 1,272 | $79K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,947 | $78K |
| 85055 | <1% | 1,847 | $76K | |
| 76775 | <1% | 1,139 | $67K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 289 | $67K |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 143 | $62K |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 1,010 | $49K |
| 76642 | <1% | 1,921 | $48K | |
| 88304 | <1% | 829 | $44K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,246 | $42K |
| 77061 | <1% | 557 | $40K | |
| 93017 | <1% | 175 | $37K | |
| 77065 | Tomosynthesis, mammo | <1% | 478 | $35K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 107 | $34K |
| 97166 | <1% | 240 | $33K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 19,746 | $33K |
| 12002 | <1% | 51 | $29K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 364 | $27K |
| 90715 | <1% | 1,211 | $27K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 616 | $26K |
| 76830 | Ultrasound, transvaginal | <1% | 541 | $26K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,242 | $25K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 600 | $23K |
| 80061 | Lipid panel | <1% | 2,389 | $23K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 27 | $23K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,976 | $22K |
| 82803 | <1% | 670 | $21K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 12,293 | $20K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 955 | $20K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 26,673 | $20K |
| 85027 | <1% | 6,397 | $16K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 86 | $16K |
| 76536 | <1% | 578 | $15K | |
| 71250 | <1% | 125 | $15K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 225 | $14K |
| 85610 | <1% | 9,282 | $13K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,162 | $13K |
| 71045 | Radiologic examination, chest; single view | <1% | 10,620 | $13K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 68 | $13K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 4,565 | $13K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 13,187 | $12K |
| 82805 | <1% | 393 | $12K | |
| 87040 | <1% | 4,683 | $11K | |
| 10060 | <1% | 26 | $11K | |
| 76000 | <1% | 40 | $10K | |
| 77066 | Tomosynthesis, mammo | <1% | 125 | $10K |
| 88307 | <1% | 138 | $10K | |
| 77334 | <1% | 46 | $10K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,754 | $9K |
| 76870 | <1% | 151 | $9K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 95 | $9K |
| 70486 | <1% | 94 | $9K | |
| 72082 | <1% | 454 | $7K | |
| P9016 | Red blood cells, leukocytes reduced, each unit | <1% | 12 | $7K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 39 | $7K |
| 84439 | <1% | 1,381 | $7K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 27 | $6K |
| 96376 | <1% | 3,328 | $6K | |
| 70498 | <1% | 148 | $5K | |
| 74018 | <1% | 1,729 | $5K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 190 | $5K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 7,065 | $5K |
| 74246 | <1% | 110 | $4K | |
| 29125 | <1% | 16 | $4K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 93 | $4K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 7,691 | $4K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 13 | $4K |
| 84702 | <1% | 2,402 | $4K | |
| 97163 | <1% | 13 | $4K | |
| 83735 | <1% | 10,894 | $4K | |
| 72141 | <1% | 14 | $4K | |
| 88341 | <1% | 100 | $4K | |
| 82607 | <1% | 561 | $4K | |
| 29515 | <1% | 13 | $4K | |
| 84703 | <1% | 10,168 | $4K | |
| 85730 | <1% | 7,889 | $3K | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | <1% | 140 | $3K |
| 84484 | <1% | 12,689 | $3K | |
| 73560 | <1% | 837 | $3K | |
| 87340 | <1% | 390 | $3K | |
| C1760 | Closure device, vascular (implantable/insertable) | <1% | 86 | $3K |
| 82728 | <1% | 404 | $3K | |
| 82550 | <1% | 10,604 | $2K | |
| 73610 | <1% | 865 | $2K | |
| 73630 | <1% | 621 | $2K | |
| 97802 | <1% | 31 | $2K | |
| 70491 | <1% | 12 | $2K | |
| C1769 | Guide wire | <1% | 676 | $2K |
| 82962 | <1% | 7,820 | $2K | |
| 81001 | <1% | 7,580 | $2K | |
| C9290 | Injection, bupivacaine liposome, 1 mg | <1% | 12 | $2K |
| 86140 | <1% | 1,975 | $2K | |
| 83690 | <1% | 6,365 | $2K | |
| 73130 | <1% | 541 | $2K | |
| 80329 | <1% | 585 | $2K | |
| 73030 | <1% | 413 | $1K | |
| 83605 | <1% | 4,868 | $1K | |
| 86618 | <1% | 177 | $1K | |
| 81003 | <1% | 6,850 | $1K | |
| 72100 | <1% | 228 | $1K | |
| 82565 | <1% | 432 | $1K | |
| 84112 | <1% | 30 | $1K | |
| 36416 | <1% | 467 | $1K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 50 | $1K |
| J2704 | Injection, propofol, 10 mg | <1% | 4,603 | $1K |
| 87799 | <1% | 12 | $949.38 | |
| 87481 | <1% | 12 | $921.67 | |
| 82746 | <1% | 154 | $868.81 | |
| 83540 | <1% | 335 | $840.33 | |
| A4648 | Tissue marker, implantable, any type, each | <1% | 51 | $831.45 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,341 | $830.21 |
| 87077 | <1% | 1,448 | $816.21 | |
| 84100 | <1% | 1,163 | $814.48 | |
| 73110 | <1% | 208 | $753.86 | |
| 80320 | <1% | 3,136 | $735.11 | |
| 86480 | <1% | 12 | $705.03 | |
| 82948 | <1% | 786 | $687.08 | |
| 83550 | <1% | 282 | $666.42 | |
| 85652 | <1% | 946 | $662.58 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,695 | $598.59 |
| 87081 | <1% | 1,163 | $585.00 | |
| 85379 | <1% | 1,003 | $551.35 | |
| 86592 | <1% | 201 | $463.71 | |
| 86803 | <1% | 71 | $449.30 | |
| 87186 | <1% | 867 | $376.74 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 13 | $367.91 |
| 86703 | <1% | 25 | $361.64 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 6,514 | $348.70 |
| 87512 | <1% | 12 | $342.63 | |
| 93799 | <1% | 192 | $325.75 | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 12 | $321.98 |
| 80143 | <1% | 1,308 | $319.50 | |
| 73080 | <1% | 95 | $306.09 | |
| 96368 | <1% | 81 | $285.53 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 7,858 | $284.27 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 4,301 | $269.67 |
| 72170 | <1% | 60 | $253.45 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 4,504 | $247.17 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 8,624 | $219.06 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 12 | $186.75 |
| 87147 | <1% | 713 | $183.67 | |
| 86800 | <1% | 14 | $181.60 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,691 | $175.61 |
| 82570 | <1% | 42 | $175.52 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 2,449 | $167.64 |
| 80179 | <1% | 1,247 | $164.91 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,495 | $120.30 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 2,686 | $108.06 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,638 | $98.45 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 2,635 | $97.77 |
| 86780 | <1% | 14 | $97.38 | |
| 87205 | <1% | 309 | $92.04 | |
| 76857 | <1% | 14 | $91.14 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 2,387 | $89.26 |
| 84145 | <1% | 163 | $79.55 | |
| 73090 | <1% | 26 | $75.28 | |
| 87070 | <1% | 191 | $73.04 | |
| 73590 | <1% | 34 | $70.85 | |
| 82553 | <1% | 226 | $69.72 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 769 | $61.96 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 954 | $55.80 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 184 | $51.61 |
| 84520 | <1% | 12 | $47.95 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 462 | $44.37 |
| J3480 | Injection, potassium chloride, per 2 meq | <1% | 165 | $25.94 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 241 | $17.08 |
| 83615 | <1% | 15 | $8.05 | |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | <1% | 618 | $6.19 |
| 93041 | <1% | 136 | $4.88 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 106 | $2.65 |
| 99080 | 0% | 8,400 | $0.00 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 71 | $0.00 |
| J3370 | Injection, vancomycin hcl, 500 mg | 0% | 17 | $0.00 |
| 87899 | 0% | 29 | $0.00 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 99 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 23 | $0.00 |
| J0694 | Injection, cefoxitin sodium, 1 gm | 0% | 16 | $0.00 |
| 82272 | 0% | 12 | $0.00 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 40 | $0.00 |
| 99152 | 0% | 12 | $0.00 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 0% | 60 | $0.00 |
| 87807 | 0% | 32 | $0.00 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 0% | 204 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 176 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 100 | $0.00 |
| J1630 | Injection, haloperidol, up to 5 mg | 0% | 43 | $0.00 |
| S2900 | Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure) | 0% | 57 | $0.00 |
| 82150 | 0% | 12 | $0.00 | |
| 82270 | 0% | 14 | $0.00 | |
| 88300 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSCHEUERMANN, WILLIAM (VP OF REVENUE STRATEGY)
| Provider | Location | Paid |
|---|---|---|
| Garnet Health Medical Center Catskills | Harris, NY | $21.96M |
| Garnet Health Medical Center Catskills | Callicoon, NY | $941K |
| Garnet Health Medical Center | Middletown, NY | $44K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.